DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Wu H, Hu C, Wang A. et al.
Ibrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.
Leukemia 2016;
30 (03) 754-757
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.